Cargando…

Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C

Detalles Bibliográficos
Autor principal: Imaging, Contrast Media & Molecular
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372329/
https://www.ncbi.nlm.nih.gov/pubmed/37520039
http://dx.doi.org/10.1155/2023/9895013
_version_ 1785078350354579456
author Imaging, Contrast Media & Molecular
author_facet Imaging, Contrast Media & Molecular
author_sort Imaging, Contrast Media & Molecular
collection PubMed
description
format Online
Article
Text
id pubmed-10372329
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103723292023-07-28 Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C Imaging, Contrast Media & Molecular Contrast Media Mol Imaging Retraction Hindawi 2023-07-19 /pmc/articles/PMC10372329/ /pubmed/37520039 http://dx.doi.org/10.1155/2023/9895013 Text en Copyright © 2023 Contrast Media & Molecular Imaging. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Imaging, Contrast Media & Molecular
Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
title Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
title_full Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
title_fullStr Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
title_full_unstemmed Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
title_short Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
title_sort retracted: efficacy and safety of peginterferon α-2a and entecavir tenofovir in the treatment of chronic hepatitis b genotype c
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372329/
https://www.ncbi.nlm.nih.gov/pubmed/37520039
http://dx.doi.org/10.1155/2023/9895013
work_keys_str_mv AT imagingcontrastmediamolecular retractedefficacyandsafetyofpeginterferona2aandentecavirtenofovirinthetreatmentofchronichepatitisbgenotypec